Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

New strategies in immunosuppression.

M B Regazzi¹, M Alessiani, M Rinaldi

¹Department of Pharmacology, IRCCS Policlinico S. Matteo, Pavia, Italy. regazzim@smatteo.pv.it

Transplantation Proceedings

|September 27, 2005

Summary

New immunosuppressive strategies aim to prevent transplant rejection and minimize side effects. Research explores personalized medicine, novel drug formulations like modified-release tacrolimus, and antibody therapies to improve long-term graft survival.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Poor patient awareness and frequent misdiagnosis of migraine: findings from a large transcontinental cohort.

European journal of neurology·2019

Same author

Comment on "LncRNA 00152 promotes the development of hepatocellular carcinoma by activating JAK2/STAT3 pathway".

European review for medical and pharmacological sciences·2019

Same author

The impact of carbapenemase-producing Enterobacteriaceae colonization on infection risk after liver transplantation: a prospective observational cohort study.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2019

Same author

Comment on: Expressions of MiR-132 in patients with chronic hepatitis B, posthepatitic cirrhosis and hepatitis B virus-related hepatocellular carcinoma.

European review for medical and pharmacological sciences·2019

Same author

Quality and management care improvement of patients with chronic kidney disease: from data analysis to the definition of a targeted clinical pathway in an Italian Region.

Journal of preventive medicine and hygiene·2019

Same author

Comment on: LncRNA SBF2-AS1 promotes hepatocellular carcinoma metastasis by regulating EMT and predicts unfavorable prognosis.

European review for medical and pharmacological sciences·2019

Area of Science:

Immunosuppression
Transplant medicine
Pharmacology

Background:

Graft rejection (acute and chronic) remains a significant challenge in transplantation.
Minimizing side effects and toxicity is crucial for graft survival and patient well-being.
Individualized treatment strategies are needed due to variations in drug pharmacokinetics, pharmacodynamics, and pharmacogenetics.

Purpose of the Study:

To review current and emerging immunosuppressive strategies in organ transplantation.
To highlight advancements in drug formulations and therapeutic approaches.
To discuss the goal of improving long-term transplant outcomes and patient survival.

Main Methods:

Review of current literature on immunosuppressive strategies.

Related Experiment Videos

Discussion of novel drug formulations, including modified-release tacrolimus (MR4).

Analysis of the role of monoclonal/polyclonal antibodies and steroid discontinuation protocols.

Main Results:

Modified-release tacrolimus (MR4) shows comparable steady-state exposure to twice-daily administration.
Early steroid discontinuation with antibody induction may not benefit all patient subgroups.
New drug combinations have improved short-term transplant outcomes.

Conclusions:

Optimizing immunosuppression is key to preventing acute and chronic rejection.
Personalized approaches considering pharmacogenetics and novel drug delivery systems are essential.
The focus is shifting towards improving long-term graft survival and preventing chronic rejection.